← Human Trials & Peer-Reviewed Studies
Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
Plain-language guide to PMID 24476504 (2014): pilot observational study of hCG (human chorionic gonadotropin) and HMG (Human Menopausal Gonadotropin).
Key Facts
- PMID
- 24476504
- Journal
- Reproductive biology and endocrinology : RB&E
- Year
- 2014
- Study type
- Observational Study
- Authors
- Requena A et al. (4 authors)
- DOI
- 10.1186/1477-7827-12-10
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of hCG (human chorionic gonadotropin) and HMG (Human Menopausal Gonadotropin), published as an observational study.
Therefore, the researchers aimed to determine whether there are similarities in the endocrine and follicular profiles of serum and follicular fluid from controlled ovarian stimulation with the recombinant gonadotropins follicle-stimulating hormone plus luteinizing hormone (rFSH + rLH) or highly purified human menopausal gonadotropin (HP-hMG).
Results were analyzed using Student's t-test to compare continuous variables and the chi-squared test to compare proportions.
Why It Was Studied
Luteinizing hormone (LH) activity in human menopausal gonadotropin (hMG) preparations is derived from human chorionic gonadotropin (hCG) rather than LH.
Who Took Part
PubMed indexes the participants as young adults and adults, women only.
How the Study Was Run
In design terms this was a pilot study.
It is described as a pilot, a small early test of whether a larger hCG (human chorionic gonadotropin) study would be practical.
The researchers performed a prospective observational study with 50 oocyte donors that received either a combination of recombinant gonadotropins (rFSH + rLH) or a mixture of urinary gonadotropins (HP-hMG) plus purified urinary FSH (uFSH).
What Was Measured
The subject headings attached to it are Chorionic Gonadotropin, Endocrine System, Feasibility Studies, Follicle Stimulating Hormone, Luteinizing Hormone, Menotropins and Oocyte Donation.
What This Means in Plain Language
The paper is a pilot study of hCG (human chorionic gonadotropin) and HMG (Human Menopausal Gonadotropin).
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2014 (Reproductive biology and endocrinology : RB&E), a journal based in England.
More context: the hCG (human chorionic gonadotropin) compound page and the HMG (Human Menopausal Gonadotropin) compound page, all human trials.
Our Notes on the Compounds
hCG (human chorionic gonadotropin): An LH analog that drives Leydig-cell testosterone production.
HMG (Human Menopausal Gonadotropin): Menotropins: a glycoprotein preparation that supplies follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.